PMID: 9588840May 20, 1998Paper

Viral targets for antisense oligonucleotides: a mini review

Antiviral Research
A K Field

Abstract

No abstract listed.

References

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M L Stephenson, P C Zamecnik

In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription

Nov 25, 1992·Nucleic Acids Research·B BordierL Sarih-Cottin

Epstein-Barr viral latency and cell immortalization as targets for antisense oligomers.

Oct 28, 1992·Annals of the New York Academy of Sciences·J S PaganoJ C Lin

Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices

Jul 21, 1992·Nucleic Acids Research·R A StullF C Szoka

Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers

Jun 23, 1992·Biochemical Pharmacology·S AustermannF Grosse

The inhibitory effects of oligonucleotides, complementary to Marek's disease virus mRNA transcribed from the BamHI-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1

May 1, 1991·The Journal of General Virology·M KawamuraS Namioka

Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4

Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M KulkaP O Ts'o

Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides

Jan 1, 1993·Nucleic Acids Symposium Series·T HattaH Takaku

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

Oct 11, 1994·Nucleic Acids Research·O ZelphatiL Leserman

Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles

Sep 29, 1995·Journal of Medicinal Chemistry·L B TownsendJ C Drach

Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates

Nov 14, 1995·Biochemistry·J M KeanL Aurelian

Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37.

May 1, 1995·Antimicrobial Agents and Chemotherapy·G S PariJ A Smith

Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides

Sep 13, 1993·FEBS Letters·T HattaH Takaku

CpG motifs in bacterial DNA trigger direct B-cell activation

Apr 6, 1995·Nature·A M KriegD M Klinman

Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine

Jan 1, 1995·Antiviral Research·S M FennewaldR F Rando

Improved anti-herpes simplex virus type 1 activity of a phosphodiester antisense oligonucleotide containing a 3'-terminal hairpin-like structure

Jan 1, 1994·Antisense Research and Development·B PoddevinM Blumenfeld

Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome

Mar 1, 1995·Journal of Virology·M I AnazodoJ A Wright

Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication

Mar 1, 1995·Journal of Virology·J A Smith, G S Pari

Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion

Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J R WyattD J Ecker

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

Jan 1, 1994·Antisense Research and Development·C A Stein, A M Krieg

Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1.

Apr 1, 1994·Antimicrobial Agents and Chemotherapy·M KulkaL Aurelian

Selection of antisense oligonucleotides on the basis of genomic frequency of the target sequence

Jan 1, 1994·Antisense Research and Development·J HanW H Finley

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus

Jan 1, 1994·The Journal of General Virology·C AitkenT B Sculley

Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication

Dec 1, 1993·Journal of Virology·G S Pari, D G Anders

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region.

Sep 1, 1993·Antimicrobial Agents and Chemotherapy·R F AzadK P Anderson

Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1

Jun 25, 1993·Nucleic Acids Research·M HomannM Tabler

In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts.

Feb 1, 1993·Antimicrobial Agents and Chemotherapy·L M CowsertC K Mirabelli

Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5

Feb 1, 1993·Antiviral Research·M KulkaL Aurelian

Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120

Jan 1, 1993·Antisense Research and Development·C A SteinS Lederman

Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1

Jan 1, 1993·Antisense Research and Development·G SczakielK Rittner

Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome

Dec 12, 1995·Gene·M I AnazodoJ A Wright

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.

Nov 1, 1995·Antimicrobial Agents and Chemotherapy·J O OjwangT L Wallace

Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.

Mar 8, 1996·The Journal of Biological Chemistry·J S BishopN Chaudhary

Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro

Nov 1, 1995·Antiviral Research·B E Korba, J L Gerin

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries

May 15, 1996·Nucleic Acids Research·S P HoG L Trainor

Progress in antisense oligonucleotide therapeutics

Jan 1, 1996·Annual Review of Pharmacology and Toxicology·S T Crooke, C F Bennett

Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication

Mar 1, 1996·Antiviral Research·M DiabataC Mulder

Antiviral activity of an oligo(nucleoside methylphosphonate) that targets HSV-1 immediate-early pre-mRNA 4,5 is augmented by cotreatment with replication-defective adenovirus

Jan 1, 1995·Antisense Research and Development·M Kulka, L Aurelian

A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest

Feb 1, 1996·Journal of Biochemistry·T Z ChenL C Au

Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides

Feb 1, 1997·Antiviral Research·S JairathR E Kilkuskie

Antisense inhibition of virus infections

Jan 1, 1997·Advances in Pharmacology·R E Kilkuskie, A K Field

Comparative pharmacokinetics of antisense oligonucleotides

Jan 1, 1996·Methods in Molecular Medicine·S Agrawal, J Temsamani

❮ Previous
Next ❯

Citations

Delivery systems for antisense oligonucleotides

Sep 29, 2000·Pharmacology & Therapeutics·C Garcia-ChaumontJ Bolard

Inhibition of ampicillin-resistant bacteria by novel mono-DNAzymes and di-DNAzyme targeted to beta-lactamase mRNA

Aug 6, 2004·Oligonucleotides·Fei ChenJin Zhang

The evolution of antiviral therapy for external ocular viral infections over twenty-five years

Sep 29, 2000·Cornea·Y J Gordon

Oligonucleotides as antivirals: dream or realistic perspective?

Apr 20, 2006·Antiviral Research·Arthur Van Aerschot

Human cytomegalovirus: challenges, opportunities and new drug development

Nov 26, 1999·Antiviral Chemistry & Chemotherapy·A K Field

Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme.

Jun 8, 1999·The Journal of Biological Chemistry·L Q SunA King

Chemotherapy of respiratory viruses: prospects and challenges

Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Philip R. Wyde

Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility

Feb 27, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Avi SchroederYechezkel Barenholz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved